Skip to main content

Peer Review reports

From: Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

Original Submission
22 Mar 2023 Submitted Original manuscript
10 Apr 2023 Author responded Author comments - Jin Zhou
Resubmission - Version 2
10 Apr 2023 Submitted Manuscript version 2
12 Apr 2023 Author responded Author comments - Jin Zhou
Resubmission - Version 3
12 Apr 2023 Submitted Manuscript version 3
Publishing
13 Apr 2023 Editorially accepted
19 May 2023 Article published 10.1186/s12890-023-02432-5

You can find further information about peer review here.

Back to article page